{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:00:31Z","timestamp":1761894031584},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1975,1,1]],"date-time":"1975-01-01T00:00:00Z","timestamp":157766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1975]]},"DOI":"10.1007\/bf00421193","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T04:47:06Z","timestamp":1100062026000},"page":"105-110","source":"Crossref","is-referenced-by-count":82,"title":["The effect of l-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs"],"prefix":"10.1007","volume":"44","author":[{"given":"Jes","family":"Gerlach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"L\ufffdhdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00429276","volume":"29","author":"N.-E. And\u00e9n","year":"1973","unstructured":"And\u00e9n, N.-E., Str\u00f6mbom, U., Svensson, T.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression. Psychopharmacologia (Berl.) 29, 289?298 (1973)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429294","volume":"31","author":"B. Angrist","year":"1973","unstructured":"Angrist, B., Sathananthan, G., Gershon, S.: Behavioural effect of l-Dopa in schizophrenic patients. Psychopharmacologia (Berl.) 31, 1?12 (1973a)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/B978-0-08-017922-3.50189-1","volume-title":"Frontiers in catecholamine research","author":"B. Angrist","year":"1973","unstructured":"Angrist, B., Sathananthan, G., Wilk, S., Gershon, S.: Behavioural and biochemical effects of l-Dopa in psychiatric patients. In: Frontiers in catecholamine research. 3rd Intern. Catecholamine Symp. Strasbourg-Fr. E. Usdin and S. Snyder, eds., pp. 991?994. Oxford: Pergamon 1973b"},{"key":"CR4","first-page":"791","volume":"101","author":"A. Barbeau","year":"1969","unstructured":"Barbeau, A.: l-Dopa therapy in Parkinson's disease: a critial review of nine years' experience. Canad. med. Ass. J. 101, 791?800 (1969)","journal-title":"Canad. med. Ass. J."},{"key":"CR5","first-page":"9","volume-title":"l-Dopa and behavior","author":"A. Barbeau","year":"1972","unstructured":"Barbeau, A.: Dopamine and mental function. In: l-Dopa and behavior, S. Malitz, ed., pp. 9?33. New York: Raven Press 1972"},{"key":"CR6","first-page":"347","volume-title":"Advances in neurology, vol. 5","author":"A. Barbeau","year":"1974","unstructured":"Barbeau, A.: The clinical physiology of side effects in longterm l-Dopa therapy. In: Advances in neurology, vol. 5. Fl. H. McDowell and A. Barbeau, eds., pp. 347?365. New York: Raven Press 1974"},{"key":"CR7","first-page":"235","volume-title":"Dementia praecox or the group of schizophrenia","author":"E. Bleuler","year":"1950","unstructured":"Bleuler, E.: Dementia praecox or the group of schizophrenia, pp. 235?239. New York: International Universities Press 1950"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0447.1966.tb01931.x","volume":"42","author":"A. Bruno","year":"1966","unstructured":"Bruno, A., Bruno, S.: Effects of l-Dopa on pharmacological parkinsonism. Acta psychiat. scand. 42, 264?271 (1966)","journal-title":"Acta psychiat. scand."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/archneur.1970.00480270003001","volume":"23","author":"G. Celesia","year":"1970","unstructured":"Celesia, G., Barr, A.: Psychosis and other psychiatric manifestations of levodopa therapy. Arch. Neurol. (Chic.) 23, 1993?2000 (1970)","journal-title":"Arch. Neurol. (Chic.)"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1974.tb08044.x","volume":"249","author":"Z. Cesarec","year":"1974","unstructured":"Cesarec, Z., Eberhard, G., Nordgren, L.: A controlled study of the antipsychotic and sedative effects of neuroleptic drugs and amphetamine in chronic schizophrenics. Acta psychiat. scand. Suppl. 249, 65?77 (1974)","journal-title":"Acta psychiat. scand. Suppl."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.1971.03190260019005","volume":"218","author":"G. Cotzias","year":"1971","unstructured":"Cotzias, G.: Levodopa in the treatment of Parkinsonism. J. Amer. med. Ass. 218, 1903?1908 (1971)","journal-title":"J. Amer. med. Ass."},{"key":"CR12","first-page":"123","volume":"67","author":"J. Delay","year":"1959","unstructured":"Delay, J., Deniker, P., Robert, R., Beek, H., Barande, R., Eurieult, M.: Syndromes neurologiques exp\u00e9rimentaux et th\u00e9rapeutique psychiatrique. I. \u00e9ffects neurologiques d'un nouveau neuroleptique majeur, le 7843 RP. Press med. 67, 123 (1959)","journal-title":"Press med."},{"key":"CR13","first-page":"57","volume-title":"l-Dopa and behavior","author":"R. Duvoisin","year":"1972","unstructured":"Duvoisin, R., Yahr, M.: Behavioural abnormalities occurring in Parkinsonism during treatment with l-Dopa. In: l-Dopa and behavior, S. Malitz, ed., pp. 57?72. New York: Raven Press 1972"},{"key":"CR14","first-page":"252","volume":"9","author":"Y. Ginath","year":"1974","unstructured":"Ginath, Y., Lavy, S., Abramsky, O., Carmon, A.: Mental complications of l-Dopa therapy in Parkinson's patients. Israel Ann. Psychiat. Related Disciplines 9, 252?264 (1974)","journal-title":"Israel Ann. Psychiat. Related Disciplines"},{"key":"CR15","first-page":"310","volume-title":"Handbook of psychiatry","author":"S. Glasner","year":"1969","unstructured":"Glasner, S.: The schizophrenias. In: Handbook of psychiatry. P. Solomon and V. Patch, eds., pp. 310?324. Los Altos: Lange Medical Publications 1969"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.1971.03190260031009","volume":"218","author":"F. Goodwin","year":"1971","unstructured":"Goodwin, F.: Psychiatric side effects of levodopa in man. J. Amer. med. Ass. 218, 1915?1920 (1971)","journal-title":"J. Amer. med. Ass."},{"key":"CR17","first-page":"229","volume-title":"Psychopharmacology, sexual disorders and drug","author":"K. Inanaga","year":"1973","unstructured":"Inanaga, K., Tanaka, M.: Effects of l-Dopa on schizophrenia. In: Psychopharmacology, sexual disorders and drug, T. A. Ban, J. R. Boissier, G. J. Gessa, H. Heimann, L. Hollister, H. E. Lehmann, I. Munkvad, H. Steiberg, F. Sulser, A. Sundwall, and O. Vinar, eds., pp. 229?233. Amsterdam-London: North-Holland and Prague: Avicenum, Czechoslovak Medical Press 1973"},{"key":"CR18","first-page":"711","volume":"33","author":"H. Klawans","year":"1972","unstructured":"Klawans, H., Goetz, C., Westheimer, R.: Pathophysiology of schizophrenia and the striatum. Dis. nerv. Syst. 33, 711?719 (1972)","journal-title":"Dis. nerv. Syst."},{"key":"CR19","first-page":"15","volume":"187","author":"P. Langelier","year":"1973","unstructured":"Langelier, P., Roberge, A., Boucher, R., Poirier, L.: Effects of chronically administered l-Dopa in normal and lesioned cats. J. Pharmacol. exp. Ther. 187, 15?26 (1973)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-8993(74)90643-X","volume":"77","author":"C. Marsden","year":"1974","unstructured":"Marsden, C., Dolphin, A., Duvoisin, R., Jenner, P., Tarsy, D.: Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Res. 77, 521?525 (1974)","journal-title":"Brain Res."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00429385","volume":"27","author":"D. Murphy","year":"1972","unstructured":"Murphy, D., Henry, G., Weingartner, H.: Catecholamines and memory: Enhanced verbal learning during l-Dopa administration. Psychopharmacologia (Berl.) 27, 319?326 (1972)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR22","first-page":"473","volume":"74","author":"I. M\u00d8ller Nielsen","year":"1974","unstructured":"M\u00d8ller Nielsen, I.: Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects. In: Clinical physiognomy of thioxanthenes. Acta psychiat. belg. 74, 473?484 (1974)","journal-title":"Acta psychiat. belg."},{"issue":"Suppl. 2","key":"CR23","first-page":"68","volume":"5","author":"I. M\u00d8ller Nielsen","year":"1974","unstructured":"M\u00d8ller Nielsen, I., Christensen, A. V.: Long term effects of neuroleptics drugs. J. Pharmacol. 5, Suppl. 2, 68 (1974)","journal-title":"J. Pharmacol."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"J. Overall","year":"1962","unstructured":"Overall, J., Gorham, D.: The brief psychiatric rating scale. Psychol. Rep. 10, 799?812 (1962)","journal-title":"Psychol. Rep."},{"key":"CR25","first-page":"2","volume":"1","author":"A. Randrup","year":"1972","unstructured":"Randrup, A., Munkvad, I.: Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolecular Psychiat. 1, 2?7 (1972)","journal-title":"Orthomolecular Psychiat."},{"key":"CR26","volume-title":"l-Dopa and Parkinsonism. A psychological assessment","author":"M. Riklan","year":"1973","unstructured":"Riklan, M.: l-Dopa and Parkinsonism. A psychological assessment. Springfield, Ill.: Thomas 1973"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1973.04200020023003","volume":"29","author":"J. Stevens","year":"1973","unstructured":"Stevens, J.: An anatomy of schizophrenia? Arch. gen. Psychiat. 29, 177?189 (1973)","journal-title":"Arch. gen. Psychiat."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00402762","volume":"18","author":"R. Svensson","year":"1970","unstructured":"Svensson, R., Waldeck, B.: On the role of catecholamines in motor activity: Experiments with inhibitors of synthesis and of monoamine oxidase. Psychopharmacologia (Berl.) 18, 357?365 (1970)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.103.430.197","volume":"103","author":"P. Venables","year":"1957","unstructured":"Venables, P.: A short scale for rating ?activity-withdrawal? in schizophrenics. J. ment. Sci. 103, 197?199 (1957)","journal-title":"J. ment. Sci."},{"key":"CR30","first-page":"528","volume":"12","author":"J. Yaryura-Tobias","year":"1970","unstructured":"Yaryura-Tobias, J., Diamon, B., Merlis, S.: The action of l-Dopa on schizophrenic patients (a preliminary report). Curr. ther. Res. 12, 528?531 (1970)","journal-title":"Curr. ther. Res."},{"key":"CR31","first-page":"121","volume-title":"l-Dopa and behavior","author":"J. Yaryura-Tobias","year":"1972","unstructured":"Yaryura-Tobias, J., Diamond, B., Merlis, S.: l-Dopa: A psychiatric tool. In: l-Dopa and behavior, S. Malitz, ed., pp. 121?130. New York: Raven Press 1972"}],"container-title":["Psychopharmacologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00421193\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T23:58:04Z","timestamp":1554335884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00421193"}},"subtitle":["A double-blind cross-over trial with madopar and placebo"],"short-title":[],"issued":{"date-parts":[[1975]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1975]]}},"alternative-id":["BF00421193"],"URL":"https:\/\/doi.org\/10.1007\/bf00421193","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975]]}}}